Read + Share
Amedeo Smart
Independent Medical Education
Huang Y, Chen M, Yang C, Ruan J, et al. Sirolimus is effective for refractory/relapsed/intolerant acquired pure red cell aplasia: results of a prospective single-institutional trial. Leukemia 2022;36:1351-1360.PMID: 35256763
Email
LinkedIn
Facebook
Twitter
Privacy Policy